Glucan 1,4-a-glucosidase
Glucan 1,4-alpha-glucosidase is an enzyme that plays a crucial role in the breakdown of glycogen, a polysaccharide that serves as a form of energy storage in animals and fungi. This enzyme catalyzes the hydrolysis of terminal 1,4-linked alpha-D-glucose residues successively from the non-reducing ends of glycogen, releasing glucose. It is also known as glycogen debranching enzyme and is involved in the process of glycogenolysis.
Function[edit | edit source]
Glucan 1,4-alpha-glucosidase is essential for the proper metabolism of glycogen. In the liver, the glucose released by the action of this enzyme helps maintain blood sugar levels between meals. In muscles, the glucose is used for energy production. This enzyme not only aids in the breakdown of glycogen but also in the structure remodeling of glycogen, ensuring its bioavailability for further metabolic processes.
Structure[edit | edit source]
The enzyme is a complex protein that may vary in structure among different species. However, it typically contains multiple domains responsible for its enzymatic activity, including a catalytic domain that interacts with glycogen and a glucosidase domain that cleaves the alpha-1,4 glycosidic bonds.
Clinical Significance[edit | edit source]
Mutations in the gene encoding Glucan 1,4-alpha-glucosidase can lead to a range of metabolic disorders, most notably Glycogen storage disease type III (GSD III), also known as Cori disease or Forbes disease. GSD III is characterized by an accumulation of abnormally structured glycogen, which can lead to liver enlargement, hypoglycemia, and muscle weakness.
Treatment and Management[edit | edit source]
Management of conditions related to Glucan 1,4-alpha-glucosidase deficiency typically involves dietary modifications to manage hypoglycemia and prevent muscle wasting. In some cases, enzyme replacement therapy may be considered as a treatment option.
Research Directions[edit | edit source]
Research into Glucan 1,4-alpha-glucosidase continues to explore its potential in treating metabolic disorders, with a focus on developing more effective enzyme replacement therapies and understanding the enzyme's role in glycogen metabolism.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD